The Zearalenone Antibody Market Size was valued at USD 11.8 Mn in 2023 and is predicted to reach USD 45.4 Mn by 2031 at an 18.7% CAGR during the forecast period for 2024-2031.
Zearalenone antibodies can detect and bind to the mycotoxin zearalenone that fusarium produces. Several different Assays and diagnostic tests use the antibody to identify and quantify zearalenone in food and feed samples. This helps to ensure that agricultural and food safety standards and regulatory compliance are met. A growing number of people worldwide are becoming increasingly concerned about the quality and safety of food, pushing up the need for zearalenone antibodies. As a result of technological improvements in immunoassay methods, the performance and accuracy of detection have improved, which has contributed to the expansion of the market. Increased investments in research and development and agricultural initiatives are known to impact the demand for zearalenone antibodies. Additionally, technological advances in zearalenone antibodies increase the adoption of zearalenone antibody-based tests and support ongoing research and development, driving market growth and ensuring high food safety standards.
However, the market growth is hampered by the accessibility and affordability of zearalenone antibodies, which can hinder rising concerns about food safety, strict regulations, and high costs. The market for zearalenone antibodies was temporarily slowed because of the COVID-19 pandemic’s impact on research and supply chains. Interest and investment have been rekindled during the pandemic due to the increased emphasis on food safety and health. Zearalenone antibodies further propelled market expansion and are in great demand because developments in antibody production technology, rising research funding, and technological improvements are boosting the zearalenone antibody market by improving detection accuracy and efficiency, which in turn ensures compliance with security criteria and safeguarding public health.
The global zearalenone antibody market is segmented based on type and application. By type, it is divided into polyclonal and monoclonal. By application, it is divided into enzyme-linked immunosorbent assay, immunohistochemistry, immunofluorescence, and others.
The polyclonal zearalenone antibody market is expected to hold a major global market share in 2023 because of its low production costs, wide binding spectrum, and ease of application. These antibodies can detect zearalenone by binding to several epitopes, which makes them more sensitive and reliable in diagnostic settings. Because of their adaptability and low cost, they are widely used for testing and monitoring food safety.
The immunohistochemistry segment in the zearalenone antibody market is growing because immunohistochemistry is becoming increasingly important in toxicological studies and pathology, which is driving demand for zearalenone antibodies. This technique allows for the precise localization and visualization of zearalenone presence within tissue samples, which is crucial for understanding the distribution and effects of zearalenone at a cellular level and aiding research and diagnostic applications.
The North American global zearalenone antibody market is expected to register the highest market share in revenue in the near future. This is because the rising focus on upholding strict dietary and feed safety standards has led to the use of cutting-edge detection methods, including assays based on zearalenone antibodies. In addition, Asia Pacific is projected to grow rapidly in the global zearalenone antibody market because of the presence of important participants in the industry, and continuous research and development activities contribute to the expansion of the market. Moreover, demand for zearalenone antibodies is being driven by the region’s escalating need for foodstuff security measures and government initiatives that are helping to propel the market forward.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 11.8 Mn |
| Revenue Forecast In 2031 | USD 45.4 Mn |
| Growth Rate CAGR | CAGR of 18.7% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, By Application and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | LSBio, Santa Cruz Biotechnology, Merck, Biorbyt, Proteintech Group, Inc., Abcam, Creative Diagnostics, Creative Biolabs, along with other prominent players. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Zearalenone Antibody Market- By Type
Zearalenone Antibody Market- By Application
Zearalenone Antibody Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.